Repligen Corp (RGEN): Capital Expenditures
$23.52M
Year ended 2025-12-31
$22.90M
Trailing 12 months to 2026-06-30
-34.8%
3-year compound annual growth
+0.9%
5-year compound annual growth
+24.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $23.52M | -8.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $25.68M | -29.1% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $36.22M | -57.3% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $84.83M | +26.4% | 2025-03-14, From 2022-01-01 |
| 2021-12-31 | $67.09M | +198.8% | 2024-11-18, From 2021-01-01 |
| 2020-12-31 | $22.45M | +21.4% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $18.50M | +74.0% | 2022-02-17, From 2019-01-01 |
| 2018-12-31 | $10.63M | +95.0% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $5.45M | +26.1% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $4.33M | +64.6% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $2.63M | -53.1% | 2018-02-22, From 2015-01-01 |
| 2014-12-31 | $5.60M | +20.9% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $4.63M | +266.8% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $1.26M | n/a | 2015-03-17, From 2012-01-01 |
| No annual figure between 2011-03-31 and 2012-12-31. | |||
| 2011-03-31 | $524.7K | -12.2% | 2013-03-15, From 2010-04-01 |
| 2010-03-31 | $597.3K | n/a | 2012-03-15, From 2009-04-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Repligen Corp (RGEN) | 2025-12-31 | $23.52M | -8.4% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $2.47M | +119.6% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $22.57M | +174.4% |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | $9.86M | +529.2% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $28.85M | -7.0% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $4.34M | -16.1% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $6.97M | -34.8% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $11.95M | +182.0% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $28.00M | +451.7% |
Compare RGEN, BCRX, ADMA, TARS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗